Bay Area biotech company once worth $2B guts staff, departing execs get $600KSutro Biopharma faces drastic staff reductions and shifts in leadership due to ongoing financial losses.
This metabolic brain boost revives memory in Alzheimer's miceAn experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challengeFDA initiative Project Optimus aims to reduce toxicity of cancer drugs by pinpointing the right dosage before reaching patients.
Abandoning randomized controlled trials won't help cancer treatmentRandomized controlled trials (RCTs) should be phased out for cancer drugs, according to an Outlook article.
Gut microbiome discovery provides roadmap for life-saving cancer therapiesGut bacteria balance influences response to cancer drugs.